Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Dividends Paid - Preferred Dividends Paid - Preferred Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Net Income (2016 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Net Income over the past 15 years, most recently at $3000.0 for Q2 2024.

For Q2 2024, Net Income rose 100.13% year-over-year to $3000.0; the TTM value through Feb 2025 reached $3000.0, down 99.22%, while the annual FY2024 figure was $2.7 million, 107.59% up from the prior year.
Net Income for Q2 2024 was $3000.0 at Lifecore Biomedical, Inc. \De\, down from $847000.0 in the prior quarter.
Over five years, Net Income peaked at $1.8 million in Q3 2023 and troughed at -$51.6 million in Q2 2022.
A 5-year average of -$9.9 million and a median of -$3.6 million in 2022 define the central range for Net Income.
Biggest five-year swings in Net Income: tumbled 3184.9% in 2020 and later soared 143.44% in 2023.
Year by year, Net Income stood at -$4.0 million in 2020, then tumbled by 955.02% to -$42.6 million in 2021, then soared by 91.54% to -$3.6 million in 2022, then soared by 99.33% to -$24000.0 in 2023, then soared by 112.5% to $3000.0 in 2024.
Business Quant data shows Net Income for LFCR at $3000.0 in Q2 2024, $847000.0 in Q1 2024, and -$24000.0 in Q4 2023.